Iran´s significant advances in Biosimilar



20-01-2012 06:48 Iran is making significant advances in medicine production, especially in the fields of biosimilar and biotechnology drugs. Unlike the more common small-molecule drugs, biosimilars medicines are important because they exhibit high molecular complexity. With over 400 medical research facilities and 76 medical magazine indexes available in the country, Iran is looking to advance in the next 10 years to become one of the top 10 ranked countries in the world in medical research.

The rest is here:
Iran´s significant advances in Biosimilar

Related Posts

Comments are closed.